SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 607.82 |
Enterprise Value ($M) | 578.38 |
Book Value ($M) | 463.79 |
Book Value / Share | 1.37 |
Price / Book | 1.31 |
NCAV ($M) | 449.42 |
NCAV / Share | 1.33 |
Price / NCAV | 1.35 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.20 |
Return on Assets (ROA) | -0.93 |
Return on Equity (ROE) | -0.96 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 9.04 |
Current Ratio | 9.04 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 526.25 |
Assets | 540.63 |
Liabilities | 76.84 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 7.87 |
Operating Income | -167.56 |
Net Income | -567.94 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -130.41 |
Cash from Investing | 122.70 |
Cash from Financing | 0.33 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Fmr Llc | 13.50 | ||
13D/A | Omega Fund V, L.P. | 3.90 | -13.27 | |
13D | Decheng Capital China Life Sciences USD Fund III, L.P. | 8.00 | ||
13D/A | Hung David | 27.70 | 2.72 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,289,793 | 3,491,258 | 36.94 | |
1,346,300 | 5,169,257 | 26.04 | |
967,768 | 3,856,723 | 25.09 | |
1,277,724 | 3,457,077 | 36.96 | |
(click for more detail) |
Similar Companies | |
---|---|
JNJ – Johnson & Johnson | LLY – Eli Lilly and Company |
MRK – Merck & Co., Inc. | OGN – Organon & Co. |
PBH – Prestige Consumer Healthcare Inc. |
Financial data and stock pages provided by
Fintel.io